ALX Oncology Holdings Inc (ALXO)
1.29
+0.08
(+6.61%)
USD |
NASDAQ |
Nov 21, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Market Cap: 68.04M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 63.82M |
| November 19, 2024 | 64.87M |
| November 18, 2024 | 64.35M |
| November 15, 2024 | 68.04M |
| November 14, 2024 | 70.15M |
| November 13, 2024 | 70.68M |
| November 12, 2024 | 70.68M |
| November 11, 2024 | 78.06M |
| November 08, 2024 | 76.48M |
| November 07, 2024 | 79.64M |
| November 06, 2024 | 80.70M |
| November 05, 2024 | 80.17M |
| November 04, 2024 | 78.59M |
| November 01, 2024 | 76.48M |
| October 31, 2024 | 75.42M |
| October 30, 2024 | 72.79M |
| October 29, 2024 | 73.84M |
| October 28, 2024 | 77.00M |
| October 25, 2024 | 77.53M |
| October 24, 2024 | 76.74M |
| October 23, 2024 | 87.55M |
| October 22, 2024 | 79.11M |
| October 21, 2024 | 79.11M |
| October 18, 2024 | 78.06M |
| October 17, 2024 | 79.64M |
| Date | Value |
|---|---|
| October 16, 2024 | 82.28M |
| October 15, 2024 | 82.28M |
| October 14, 2024 | 81.75M |
| October 11, 2024 | 81.22M |
| October 10, 2024 | 75.95M |
| October 09, 2024 | 85.44M |
| October 08, 2024 | 87.03M |
| October 07, 2024 | 83.86M |
| October 04, 2024 | 88.61M |
| October 03, 2024 | 90.72M |
| October 02, 2024 | 96.52M |
| October 01, 2024 | 98.10M |
| September 30, 2024 | 95.99M |
| September 27, 2024 | 103.76M |
| September 26, 2024 | 98.50M |
| September 25, 2024 | 95.34M |
| September 24, 2024 | 102.71M |
| September 23, 2024 | 104.82M |
| September 20, 2024 | 109.03M |
| September 19, 2024 | 114.30M |
| September 18, 2024 | 112.72M |
| September 17, 2024 | 114.82M |
| September 16, 2024 | 114.82M |
| September 13, 2024 | 116.93M |
| September 12, 2024 | 112.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
63.82M
Minimum
Nov 20 2024
4.166B
Maximum
Dec 10 2020
1.053B
Average
588.09M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.09B |
| Neurocrine Biosciences Inc | 12.66B |
| Eton Pharmaceuticals Inc | 276.96M |
| Verve Therapeutics Inc | 389.03M |
| Immuneering Corp | 65.52M |
Market Cap Related Metrics
| PS Ratio | 17.99 |
| Price to Book Value | 0.4973 |
| Price | 1.29 |
| Earnings Yield | -230.2% |